These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fat necrosis mimicking B-cell lymphoma: a PET/CT and FDG study. Belakhlef A, Jani C, Church C, Fraser R, Lakhanpal S. Clin Nucl Med; 2008 Apr; 33(4):271-2. PubMed ID: 18356666 [Abstract] [Full Text] [Related]
3. CA 15.3 measurements for separating FDG PET/CT positive from negative findings in breast carcinoma recurrence. Factors influencing the area under the ROC curve. Kruse V, Van de Wiele C, Borms M, Maes A, Pottel H, Sathekge M, Cocquyt V. Nuklearmedizin; 2014 Aug 06; 53(4):131-8. PubMed ID: 25100557 [Abstract] [Full Text] [Related]
4. Recurrent and metastatic breast cancer PET, PET/CT, PET/MRI: FDG and new biomarkers. Gaeta CM, Vercher-Conejero JL, Sher AC, Kohan A, Rubbert C, Avril N. Q J Nucl Med Mol Imaging; 2013 Dec 06; 57(4):352-66. PubMed ID: 24322792 [Abstract] [Full Text] [Related]
5. Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer. Dirisamer A, Halpern BS, Flöry D, Wolf F, Beheshti M, Mayerhoefer ME, Langsteger W. Eur J Radiol; 2010 Feb 06; 73(2):294-9. PubMed ID: 19181468 [Abstract] [Full Text] [Related]
8. Comparison of 18F-FDG positron emission tomography/computed tomography and computed tomography in patients with already-treated breast cancer: diagnostic and prognostic implications. Evangelista L, Baretta Z, Vinante L, Bezzon E, De Carolis V, Cervino AR, Gregianin M, Ghiotto C, Saladini G, Pomerri F, Muzzio PC. Q J Nucl Med Mol Imaging; 2012 Aug 06; 56(4):375-84. PubMed ID: 23013667 [Abstract] [Full Text] [Related]
9. Role of combined BI-RADS assessment using mammography and sonography for evaluation of incidental hypermetabolic lesions in the breast on 18F-FDG PET-CT. Lim S, Lee EH, Park JM, Chang YW, Kim HH, Jeong SH. Acta Radiol; 2013 Dec 06; 54(10):1117-24. PubMed ID: 23864064 [Abstract] [Full Text] [Related]
10. Disseminated tuberculosis masquerading as metastatic breast carcinoma on PET-CT. Das CJ, Kumar R, Balakrishnan VB, Chawla M, Malhotra A. Clin Nucl Med; 2008 May 06; 33(5):359-61. PubMed ID: 18431158 [Abstract] [Full Text] [Related]
12. Benign schwannoma in supraclavicular region: a false-positive lymph node recurrence of breast cancer suspected by PET scan. Perniola G, Tomao F, Fischetti M, Lio S, Pecorella I, Benedetti Panici P. Arch Gynecol Obstet; 2014 Sep 06; 290(3):583-6. PubMed ID: 24744055 [Abstract] [Full Text] [Related]
13. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma. Arush MW, Israel O, Postovsky S, Militianu D, Meller I, Zaidman I, Sapir AE, Bar-Shalom R. Pediatr Blood Cancer; 2007 Dec 06; 49(7):901-5. PubMed ID: 17252575 [Abstract] [Full Text] [Related]
18. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound. Fakhry N, Michel J, Colavolpe C, Varoquaux A, Dessi P, Giovanni A. Clin Otolaryngol; 2012 Jun 06; 37(3):197-206. PubMed ID: 22520870 [Abstract] [Full Text] [Related]
20. Delayed development of enhancement in fat necrosis after breast conservation therapy: a potential pitfall of MR imaging of the breast. Solomon B, Orel S, Reynolds C, Schnall M. AJR Am J Roentgenol; 1998 Apr 06; 170(4):966-8. PubMed ID: 9530045 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]